Trump Announces TrumpRx Partnership With Pfizer to Slash Prescription Drug Prices

President Donald Trump unveiled a new initiative aimed at making prescription medications more affordable for Americans.

The program, called TrumpRx, is a collaboration with Pfizer that allows patients to purchase select medications directly through a government-backed platform at discounted rates negotiated with the company.

The White House officially unveiled TrumpRx alongside Pfizer CEO Albert Bourla during a briefing on Tuesday.

TrumpRx is designed to bypass traditional intermediaries, giving consumers the option to pay cash for select prescriptions at prices set by the federal government.

The initiative builds on the administration’s broader effort to increase transparency in drug pricing and expand direct-to-consumer access, The Post Millennial reports.

During the briefing, President Trump emphasized the burden high drug prices have placed on U.S. consumers.

“For many years, Americans have paid the highest prices anywhere in the world for prescription drugs,” he said. “Ten times, 13 times, 15 times more than other countries for the exact same product.”

“The United States accounts for just 4% of global consumers, yet pharmaceutical companies earn 75% of their profits here,” he added.